Quantitative Systematic Strategies LLC Catalent, Inc. Transaction History

Quantitative Systematic Strategies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$109.17 - $142.35 $1.16 Million - $1.51 Million	-10,639 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$100.34 - $115.69 $359,417 - $414,401	3,582 Added 50.76%	10,639 $1.15 Million
Q1 2021 May 06, 2021	SELL	$101.51 - $125.27 $949,423 - $1.17 Million	-9,353 Reduced 57.0%	7,057 $743,000
Q4 2020 Feb 09, 2021	SELL	$85.88 - $105.36 $668,146 - $819,700	-7,780 Reduced 32.16%	16,410 $1.71 Million
Q3 2020 Nov 09, 2020	SELL	$72.74 - $92.5 $427,856 - $544,085	-5,882 Reduced 19.56%	24,190 $2.07 Million
Q2 2020 Aug 04, 2020	BUY	$48.02 - $79.04 $502,001 - $826,284	10,454 Added 53.29%	30,072 $2.2 Million
Q1 2020 May 06, 2020	BUY	$36.95 - $62.95 $724,885 - $1.23 Million	19,618 New	19,618 $1.02 Million
Q3 2019 Nov 07, 2019	SELL	$47.45 - $58.05 $743,351 - $909,411	-15,666 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$39.26 - $54.21 $615,047 - $849,253	15,666 New	15,666 $849,000
Q4 2017 Feb 01, 2018	SELL	$37.27 - $43.02 $1.6 Million - $1.85 Million	-42,926 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$33.75 - $41.67 $1.45 Million - $1.79 Million	42,926	42,926 $1.71 Million

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.8B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.